CapsoVision (CV) vs Quantum-Si (QSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CapsoVision (CV) has outperformed Quantum-Si (QSI) over the past year, gaining 38.9% versus a loss of 31.1%. CapsoVision is the larger company by market cap ($352.3 million vs $267.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | QSI |
|---|---|---|
| Share price | $6.62 | $1.22 |
| Market cap | $352.25M | $267.04M |
| 1-day change | +1.22% | -4.69% |
| YTD return | -38.82% | +10.91% |
| 1-year return | +38.85% | -31.07% |
| 5-year return | — | -85.12% |
| EPS (TTM) | $-0.45 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $3.10 |
| 52-week low | $4.38 | $0.69 |
| Distance from 52-week high | -56.93% | -60.65% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +43.50% | +86.89% |
| Average volume | 157.18K | 4.15M |
| Shares outstanding | 53.21M | 198.95M |
| Employees | 99 | 145 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CV has outperformed QSI by 69.9 percentage points over the past year.
- The two companies sit in different sectors: CapsoVision in Health Care and Quantum-Si in Industrials.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Quantum-Si
QSI stock →Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS.
Industrials · Industrial Machinery/Components · 145 employees
CV vs QSI FAQ
Which is bigger, CapsoVision or Quantum-Si?
CapsoVision (CV) is larger, with a market capitalization of $352.25M compared with $267.04M for Quantum-Si (QSI).
Which stock has performed better over the past year, CV or QSI?
CV returned +38.85% over the past 12 months, compared with -31.07% for QSI (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Quantum-Si in the same industry?
No. CapsoVision is in the Health Care sector, while Quantum-Si is in Industrials.